Information only — not investment advice; no trading here. Every number shows when it was observed and where it came from; stale sources are labelled as stale.

MEDP Medpace Holdings, Inc.

equity · exchange Nasdaq · CIK 0001668397 · trades in USD

AI brief AI-written, not reviewed by a person

Latest period figures show a strong cash position and growth in key profitability metrics: cash and equivalents at 2026-09-30 were 705,315,000 USD, up from 502,688,000 USD at 2026-06-30, while diluted EPS for the 12 months to 2025-12-31 was 15.28 USD and 3-month diluted EPS for 2026-09-30 was 4.84 USD. Stockholders’ equity and total assets increased in the latest quarter, with total assets at 2026-09-30 of 2,302,595,000 USD and stockholders’ equity of 584,939,000 USD, against prior periods; liabilities remained substantial but generally trended higher toward the latest period, consistent with ongoing funding activity. Revenue for the year to 2025-12-31 was 2,530,234,000 USD, with quarterly figures indicating continued top-line momentum (3Q 2026 revenue around 716,000,000 USD).

Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).

Observations

Latest observation per metric. Values are exactly as the source stated them.
MetricValueObservedSourceRetrievedFreshness
Revenue (quarter) (3 months to 2026-09-30) 716,000,000 USD sec-companyfacts current
Revenue (year) (12 months to 2025-12-31) 2,530,234,000 USD sec-companyfacts current
Net income (quarter) (3 months to 2026-09-30) 137,460,000 USD sec-companyfacts current
Net income (year) (12 months to 2025-12-31) 451,123,000 USD sec-companyfacts current
Operating income (quarter) (3 months to 2026-09-30) 165,540,000 USD sec-companyfacts current
Operating income (year) (12 months to 2025-12-31) 534,935,000 USD sec-companyfacts current
Diluted EPS (quarter) (3 months to 2026-09-30) 4.84 USD/shares sec-companyfacts current
Diluted EPS (year) (12 months to 2025-12-31) 15.28 USD/shares sec-companyfacts current
Operating cash flow (quarter) (3 months to 2026-03-31) 151,788,000 USD sec-companyfacts current
Operating cash flow (year) (12 months to 2025-12-31) 713,223,000 USD sec-companyfacts current
Total assets (at 2026-09-30) 2,302,595,000 USD sec-companyfacts current
Total liabilities (at 2026-09-30) 1,717,656,000 USD sec-companyfacts current
Stockholders' equity (at 2026-09-30) 584,939,000 USD sec-companyfacts current
Cash and equivalents (at 2026-09-30) 705,315,000 USD sec-companyfacts current
Long-term debt (at 2019-12-31) 0 USD sec-companyfacts current
Shares outstanding (at 2026-10-16) 27,971,686 shares sec-companyfacts current

Context

No reviewed context has been published for MEDP. The observations and documents below are shown as their sources stated them.

Documents

Feeds of MEDP documents: RSS · Atom · JSON Feed

Source freshness

Sources behind this page. A source is stale when its last successful fetch is older than its window.
SourceFreshnessLast successful fetchStale afterSources reports
SEC EDGAR: company financial facts (XBRL) sec-companyfacts current 10080 min ok
SEC EDGAR: latest XBRL filings sec-xbrl-filings current 45 min healthy

Watch this instrument

Sign in to add MEDP to a private watchlist or to get an alert when a new document or observation arrives.

Machine-readable: MEDP.json (the same data with every timestamp and source).

Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.